{"id":16302,"date":"2026-01-29T14:43:17","date_gmt":"2026-01-29T13:43:17","guid":{"rendered":"https:\/\/psm-saar.de\/?page_id=16302"},"modified":"2026-02-12T18:39:27","modified_gmt":"2026-02-12T17:39:27","slug":"monoclonal-antibodies","status":"publish","type":"page","link":"https:\/\/psm-saar.de\/en\/biopharmaceuticals\/monoclonal-antibodies\/","title":{"rendered":"Monoclonal Antibodies"},"content":{"rendered":"
\n
\n\n

Monoclonal Antibodies (mAbs)<\/h1>\n\n\n
\n
\n\n

A monoclonal antibody is a laboratory-produced immune system protein that binds specifically to a single, well-defined target on a cell. It originates from a single cell line and is therefore completely uniform in structure and function. Monoclonal antibodies can block disease signals, modulate immune responses, or deliver therapeutic agents directly to specific cells. They are primarily used in cancer, autoimmune, and inflammatory therapies, as well as in diagnostics.<\/p>\n\n<\/div><\/div><\/div>\n\n

\n\n

At PSM, we have focused, among other things, on monoclonal antibodies (mAbs) and offer GMP-compliant, comprehensive process solutions. This includes all processes from freezing, controlled thawing, to formulation, filling, and visual inspection. For monoclonal antibodies for rare diseases, and therefore smaller batches, we use a dedicated Groninger filling line, which significantly reduces product loss during the process compared to conventional filling lines.<\/p>\n\n<\/div><\/div><\/div>\n<\/div>\n\n\n

\n\n\n\n
\n

PSM equipment and processes are implemented for handling mAbs:<\/h2>\n<\/div>\n\n\n\n